Skip to main content
Clinical Trials/CTRI/2020/02/023208
CTRI/2020/02/023208Not yet recruiting未知

Plasma Metabolomic Profiling To Identify Metabolic Biomarkers For Early Detection Of Prediabetes Associated With Pancreatogenic Diabetes (Type3cDM) In Chronic Pancreatitis

Science and Engineering Research Board0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Inclusion Criteria

  • The diagnosis of chronic pancreatitis is based on two or more of the following findings:
  • a.Patients who have had abdominal pain of > 6 months duration without diabetes
  • b.Patients with history of recurrent acute pancreatitis with > 3 episodes of pain associated with imaging diagnostic of acute pancreatitis and/or elevated serum amylase or lipase 3 times normal.
  • c.CP diagnosed by Pancreas calcifications on CT scan, or abnormal ERCP; ductal or parenchymal abnormalities on Endoscopic ultrasonography,
  • d.Histopathologic confirmed diagnosis of chronic pancreatitis
  • Ability to give informed consent

Exclusion Criteria

  • 1.Age less than 18 or more than 60 years
  • 2.CP patients with diabetes
  • 3.CP patients with other comorbidities and Patients with grossly atrophic pancreas on imaging
  • 4.CP patients with malignancy
  • 5.Pregnant or lactating women
  • 6.Inability to give informed consent.

Investigators

Sponsor
Science and Engineering Research Board

Similar Trials